BUSINESS
F&O Buzzer | Bulls continue to fuel the fire for Apollo Hospitals
BUSINESS
Analyst Call Tracker: Why are analysts lowering expectations from HCL Technologies?
BUSINESS
Max Healthcare Institute hits 52-week high following large deal
BUSINESS
Improved sentiment, hopes of better sales fuel gains in pharma stocks; Divi's Lab spurts 8%
BUSINESS
Analyst Call Tracker: Bullish calls on RIL rise as risk-reward ratio improves
BUSINESS
Neogen Chemicals spurts 6% on pact with Japanese major for electrolyte solutions
BUSINESS
F&O Manual | Nifty likely to consolidate, analysts suggest going short
BUSINESS
JLR wholesale numbers for Jan-Mar drive Tata Motors shares to 7-month high
BUSINESS
Goldman downgrades Maruti Suzuki to 'neutral' on slowing demand for small cars
BUSINESS
Be Patient: Jefferies sees regulatory snags as buying opportunity in hospital stocks
BUSINESS
Angel One shares rise 3% as client base grows on month in March
BUSINESS
Contrarian Calls | Tech Mahindra's management rejig stirs analysts' optimism despite weak price action
BUSINESS
M&M shares rise as automaker posts highest ever auto sales in March
BUSINESS
Ashok Leyland shares gain on robust monthly sales
BUSINESS
Three pharma stocks heal the pain with up to 16% returns, boost hopes for more
BUSINESS
Lupin shares slip as US FDA issues ten observations for Pithampur unit
BUSINESS
MPP signs supply pact with Aurobindo Pharma, Cipla and Viatris for HIV drug
BUSINESS
Nirmal Bang sees 25% upside in this speciality chemicals stock. Here’s why
BUSINESS
F&O Manual: Nifty may sustain gains, F&O expiry likely around 17,100
BUSINESS
Mphasis shares rise on clarification of no exposure to collapsed US banks
BUSINESS
Know your stock | Is Eris Lifesciences on the verge of a turnaround?
BUSINESS
F&O Manual: Analysts see some pullback in Nifty ahead of expiry tomorrow
BUSINESS
F&O Manual: Volatility takes over Nifty, traders remain bearish
BUSINESS
F&O Manual: Bearish sentiment to continue, analysts suggest sell on rise
